Literature DB >> 19590626

Altered aquaporin 9 expression and localization in human hepatocellular carcinoma.

Srikanth Padma1, Alan M Smeltz, Peter M Banks, David A Iannitti, Iain H McKillop.   

Abstract

BACKGROUND: In addition to the biochemical components secreted in bile, aquaporin (AQP) water channels exist in hepatocyte membranes to form conduits for water movement between the sinusoid and the bile canaliculus. The aim of the current study was to analyse AQP 9 expression and localization in human hepatocellular carcinoma (HCC) and non-tumourigenic liver (NTL) tissue from patients undergoing hepatic resection.
METHODS: Archived tissue from 17 patients was sectioned and analysis performed using an antibody raised against AQP 9. Slides were blind-scored to determine AQP 9 distribution within HCC and NTL tissue.
RESULTS: Aquaporin 9 was predominantly expressed in the membranes of hepatocytes and demonstrated zonal distribution relative to hepatic sinusoid structure in normal liver. In HCC arising in the absence of cirrhosis AQP 9 remained membrane-localized with zonal distribution in the majority of NTL. By contrast, AQP 9 expression was significantly decreased in the HCC mass vs. pair-matched NTL. In HCC in the presence of cirrhosis, NTL was characterized by extensive AQP 9 staining in the membrane in the absence of zonal distribution and AQP 9 staining in NTL was significantly greater than that observed in the tumour mass.
CONCLUSIONS: These data demonstrate that human HCC is characterized by altered AQP 9 expression and AQP 9 localization in the NTL mass is dependent on underlying liver pathology. Given the central role of AQPs in normal liver function and the potential role of AQPs during transformation and progression, these data may prove valuable in future diagnostic and/or therapeutic strategies.

Entities:  

Keywords:  aquaporin; hepatocellular carcinoma; hepatocyte; normal liver

Year:  2009        PMID: 19590626      PMCID: PMC2697857          DOI: 10.1111/j.1477-2574.2008.00014.x

Source DB:  PubMed          Journal:  HPB (Oxford)        ISSN: 1365-182X            Impact factor:   3.647


  31 in total

1.  Expression and localization of aquaporin water channels in rat hepatocytes. Evidence for a role in canalicular bile secretion.

Authors:  Robert C Huebert; Patrick L Splinter; Fabiana Garcia; Raul A Marinelli; Nicholas F LaRusso
Journal:  J Biol Chem       Date:  2002-04-03       Impact factor: 5.157

2.  Hepatocellular carcinoma--history, current status and perspectives.

Authors:  K Okuda
Journal:  Dig Liver Dis       Date:  2002-09       Impact factor: 4.088

3.  Plasma membrane aquaporin activity can affect the rate of apoptosis but is inhibited after apoptotic volume decrease.

Authors:  Elizabeth M Jablonski; Ashley N Webb; Nisha A McConnell; Marcus C Riley; Francis M Hughes
Journal:  Am J Physiol Cell Physiol       Date:  2003-11-26       Impact factor: 4.249

Review 4.  Liver aquaporins: significance in canalicular and ductal bile formation.

Authors:  Raúl A Marinelli; Sergio A Gradilone; Flavia I Carreras; Giuseppe Calamita; Guillermo L Lehmann
Journal:  Ann Hepatol       Date:  2004 Oct-Dec       Impact factor: 2.400

Review 5.  Regulation and dysregulation of aquaporins in water balance disorders.

Authors:  S Nielsen; T-H Kwon; J Frøkiaer; P Agre
Journal:  J Intern Med       Date:  2007-01       Impact factor: 8.989

Review 6.  Bile salt excretory pump: biology and pathobiology.

Authors:  Frederick J Suchy; M Ananthanarayanan
Journal:  J Pediatr Gastroenterol Nutr       Date:  2006-07       Impact factor: 2.839

7.  Arsenite transport by mammalian aquaglyceroporins AQP7 and AQP9.

Authors:  Zijuan Liu; Jian Shen; Jennifer M Carbrey; Rita Mukhopadhyay; Peter Agre; Barry P Rosen
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-23       Impact factor: 11.205

8.  Disruption of aquaporin-11 produces polycystic kidneys following vacuolization of the proximal tubule.

Authors:  Yoshiyuki Morishita; Toshiyuki Matsuzaki; Mariko Hara-chikuma; Ayaka Andoo; Mariko Shimono; Asako Matsuki; Katsuki Kobayashi; Masahiro Ikeda; Tadashi Yamamoto; Alan Verkman; Eiji Kusano; Shigeo Ookawara; Kuniaki Takata; Sei Sasaki; Kenichi Ishibashi
Journal:  Mol Cell Biol       Date:  2005-09       Impact factor: 4.272

9.  Water transporting properties of hepatocyte basolateral and canalicular plasma membrane domains.

Authors:  Raul A Marinelli; Pamela S Tietz; Ariel J Caride; Bing Q Huang; Nicholas F LaRusso
Journal:  J Biol Chem       Date:  2003-08-25       Impact factor: 5.157

10.  Coordinated regulation of fat-specific and liver-specific glycerol channels, aquaporin adipose and aquaporin 9.

Authors:  Hiroshi Kuriyama; Iichiro Shimomura; Ken Kishida; Hidehiko Kondo; Naoki Furuyama; Hitoshi Nishizawa; Norikazu Maeda; Morihiro Matsuda; Hiroyuki Nagaretani; Shinji Kihara; Tadashi Nakamura; Yoshihiro Tochino; Tohru Funahashi; Yuji Matsuzawa
Journal:  Diabetes       Date:  2002-10       Impact factor: 9.461

View more
  10 in total

1.  Auphen and dibutyryl cAMP suppress growth of hepatocellular carcinoma by regulating expression of aquaporins 3 and 9 in vivo.

Authors:  Rui Peng; Guang-Xi Zhao; Jing Li; Yu Zhang; Xi-Zhong Shen; Ji-Yao Wang; Jian-Yong Sun
Journal:  World J Gastroenterol       Date:  2016-03-28       Impact factor: 5.742

2.  A Systematic Characterization of Aquaporin-9 Expression in Human Normal and Pathological Tissues.

Authors:  Cecilia Lindskog; Anna Asplund; Anca Catrina; Søren Nielsen; Michael Rützler
Journal:  J Histochem Cytochem       Date:  2016-03-29       Impact factor: 2.479

3.  Leptin inhibits hepatocellular carcinoma proliferation via p38-MAPK-dependent signalling.

Authors:  Kyle J Thompson; Kwan N Lau; Sarah Johnson; John B Martinie; David A Iannitti; Iain H McKillop; David Sindram
Journal:  HPB (Oxford)       Date:  2011-01-27       Impact factor: 3.647

Review 4.  Aquaporins as diagnostic and therapeutic targets in cancer: how far we are?

Authors:  Jian Wang; Li Feng; Zhitu Zhu; Minghuan Zheng; Diane Wang; Zhihong Chen; Hongzhi Sun
Journal:  J Transl Med       Date:  2015-03-21       Impact factor: 5.531

Review 5.  Hepatocyte and Sertoli Cell Aquaporins, Recent Advances and Research Trends.

Authors:  Raquel L Bernardino; Raul A Marinelli; Anna Maggio; Patrizia Gena; Ilaria Cataldo; Marco G Alves; Maria Svelto; Pedro F Oliveira; Giuseppe Calamita
Journal:  Int J Mol Sci       Date:  2016-07-09       Impact factor: 5.923

Review 6.  Gender Differences in Adipocyte Metabolism and Liver Cancer Progression.

Authors:  Otto K-W Cheung; Alfred S-L Cheng
Journal:  Front Genet       Date:  2016-09-20       Impact factor: 4.599

7.  Aquaporin 9 inhibits hepatocellular carcinoma through up-regulating FOXO1 expression.

Authors:  Chuan-Fei Li; Wen-Guang Zhang; Min Liu; Lie-Wang Qiu; Xiao-Feng Chen; Lin Lv; Zhe-Chuan Mei
Journal:  Oncotarget       Date:  2016-07-12

Review 8.  The Multifaceted Role of Aquaporin-9 in Health and Its Potential as a Clinical Biomarker.

Authors:  Inês V da Silva; Sabino Garra; Giuseppe Calamita; Graça Soveral
Journal:  Biomolecules       Date:  2022-06-27

9.  Prognostic value of combined aquaporin 3 and aquaporin 5 overexpression in hepatocellular carcinoma.

Authors:  Xiaodong Guo; Ting Sun; Mei Yang; Zhiyan Li; Zhiwei Li; Yuejuan Gao
Journal:  Biomed Res Int       Date:  2013-10-09       Impact factor: 3.411

Review 10.  Aquaglyceroporins: Drug Targets for Metabolic Diseases?

Authors:  Giuseppe Calamita; Jason Perret; Christine Delporte
Journal:  Front Physiol       Date:  2018-07-10       Impact factor: 4.566

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.